Leidos director awarded shares and stock options

Leidos Holdings director David G. Fubini received new equity compensation.

Rhea-AI Filing Summary

Leidos Holdings director David G. Fubini received new equity compensation. On May 8, 2026, he was granted 1,067 shares of common stock at no cost, increasing his direct holdings to 17,547.8435 shares. He was also awarded stock options for 1,281 shares at an exercise price of $131.26 per share.

The options relate to common stock and will vest and become exercisable in full on the earlier of the first anniversary of the grant date or the date the next annual meeting of stockholders is concluded. These Form 4 entries reflect compensation-related acquisitions rather than open-market purchases or sales.

Insider Trade Summary

Grant/Award: 2,348 shares

Grant/Award 2 txns

Insider Fubini David G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	1,281	$0.00	$0.00
Grant/Award	Common Stock	1,067	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 1,281 contracts (Direct); Common Stock — 17,547.8435 shares (Direct)

Footnotes (1)

1. F1. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.

Key Figures

Common stock grant: 1,067 shares Shares held after grant: 17,547.8435 shares Stock options granted: 1,281 options +4 more

7 metrics

Common stock grant 1,067 shares Awarded on May 8, 2026 as compensation

Shares held after grant 17,547.8435 shares Direct Leidos holdings following stock award

Stock options granted 1,281 options Awarded on May 8, 2026, underlying common stock

Option exercise price $131.26 per share Conversion or exercise price for 1,281 options

Option vesting trigger 1 year or next meeting Earlier of first anniversary or next annual stockholder meeting

Option exercise date May 8, 2027 Scheduled date from which options become exercisable, subject to vesting condition

Option expiration May 7, 2033 Expiration date for the 1,281 Leidos stock options

Key Terms

Stock Option (Right to Buy), Grant, award, or other acquisition, Common Stock, exercise price, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)" for derivative transaction"

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Common Stock financial

"security_title: "Common Stock" reported as non-derivative equity"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

exercise price financial

"conversion_or_exercise_price: "131.2600" as the option exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

annual meeting of the stockholders financial

"footnote: "the date that the next annual meeting of the stockholders of the Company is concluded""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Leidos (LDOS) director David G. Fubini report on this Form 4?

David G. Fubini reported equity compensation awards from Leidos Holdings. He received 1,067 shares of common stock at no cost and stock options for 1,281 shares, all recorded as grants or awards rather than open-market transactions.

How many Leidos (LDOS) shares does David G. Fubini hold after the reported grant?

After the common stock grant, David G. Fubini holds 17,547.8435 Leidos shares directly. This total includes the newly awarded 1,067 shares of common stock disclosed in the Form 4 filing for the transaction dated May 8, 2026.

What are the key terms of David G. Fubini’s Leidos stock options?

Fubini received stock options covering 1,281 Leidos common shares with a conversion or exercise price of $131.26 per share. The options are scheduled to become exercisable after vesting and expire on May 7, 2033, according to the Form 4 data.

When do David G. Fubini’s new Leidos stock options vest and become exercisable?

The stock options vest and become exercisable in full on the earlier of the first anniversary of the grant date or the date the next annual meeting of Leidos stockholders is concluded, as described in the Form 4 footnote.

Were David G. Fubini’s Leidos transactions open-market buys or sales?

The transactions are classified as grants or awards, not open-market buys or sales. Both the common stock and stock option entries use transaction code “A,” indicating non-market acquisitions as part of compensation, rather than discretionary trading in Leidos shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 08:58 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fubini David G

(Last) (First) (Middle)

1750 PRESIDENTS STREET

(Street)

RESTON VIRGINIA 20190

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/08/2026		A		1,067	A	$0	17,547.8435	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$131.26	05/08/2026		A		1,281		05/08/2027(1)	05/07/2033	Common Stock	1,281	$0	1,281	D

Explanation of Responses:

1. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.

Remarks:

	/s/ Ramune M. Kligys by PoA of David G. Fubini	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)